Skip to content
Sign in
Artwork for ASCO Daily News
Health & FitnessMedicine

ASCO Daily News

American Society of Clinical Oncology (ASCO)

The ASCO Daily News Podcast features oncologists discussing the latest research and therapies in their areas of expertise.

Play
Open in
  • 23 episodes
  • Avg 19 min
  • English

Episodes 23

NewestOldestLongest
All20Unplayed20In progress0Played0
Counted on this page — what you have heard stays on this device, so it is not something the list can be paged by.
  • September 10 · 20 min

    Are We Curing Advanced Melanoma? A Conversation With Dr. Jedd Wolchok

    Dr. Jedd Wolchok, a pioneer in melanoma research, joins Dr. Monty Pal to break down practice-changing advances in the field, including landmark 10-year CheckMate-067 survival data, safer immunotherapy dosing, and the rise of neoadjuvant treatment. LINK TO FULL TRANSCRIPT

  • September 3 · 23 min

    Updates in Bladder Cancer: From Intravesical Breakthroughs to Managing Toxicities

    Dr. Monty Pal and Dr. Petros Grivas discuss the rapidly evolving management of bladder cancer, including key updates in non-muscle-invasive disease, the integration of novel therapies in the advanced setting, and practical strategies for managing toxicities in clinical practice. LINK TO FULL TRANSCRIPT

  • August 20 · 21 min

    How Do We Translate ASCO26 Research Into Practice in Latin America?

    In part two of our miniseries on the global translation gap in oncology, host Dr. Monty Pal and Dr. Regina Barragán-Carrillo explore how ASCO26 Plenary breakthroughs can be adapted to clinical practice in Latin America. Together, they address real-world implementation challenges including delayed diagnoses, finite resource allocation, and access to precision diagnostics. LINK TO FULL TRANSCRIPT

  • August 6 · 18 min

    GLP-1 Receptor Agonists in GI Cancers: Hype or Promise?

    Dr. Monty Pal and Dr. Rachna Shroff explore how GLP-1 receptor agonists impact progression and survival in GI cancers, examining current retrospective data, immune microenvironment biology, and the need for prospective trials. LINK TO FULL TRANSCRIPT

  • July 23 · 24 min

    From Abstract to Action: Translating ASCO26 Research Into Global Practice

    How do we translate oncology breakthroughs into practice? In part one of a two-part miniseries, host Dr. Monty Pal and Dr. Atul Batra discuss the clinical realities, opportunities, and challenges of adapting ASCO26 Plenary findings into cancer care worldwide, using India's health care landscape as a blueprint for resource-limited settings. LINK TO FULL TRANSCRIPT

  • July 9 · 22 min

    Liquid Biopsy, AI, and Other Global Innovations From 2026 ASCO Breakthrough

    Dr. Monty Pal and Dr. Roselle De Guzman discuss key abstracts from the 2026 ASCO Breakthrough Meeting, including the real-world impact of liquid biopsies for early multi-cancer detection, AI applications in colorectal cancer screening, and how global advances in breast, esophageal, and small cell lung cancers translate directly to diverse patient populations in the Asia-Pacific region. LINK TO FULL TRANSCRIPT

  • June 2 · 9 min

    Day 5: Top Takeaways From ASCO26

    Dr. Monty Pal shares highlights from the final day of ASCO26, including new research on treating anemia in myelofibrosis, advances in RAS-mutated mCRC, novel therapies for AML, and a potentially practice-changing trial in TNBC. LINK TO FULL TRANSCRIPT

  • June 1 · 8 min

    Day 4: Top Takeaways From ASCO26

    Dr. Monty Pal shares highlights from Day 4 of the 2026 ASCO Annual Meeting, including a much-anticipated study in hepatocellular carcinoma, new data in non–small cell lung cancer, and a key update in the treatment of Merkel cell carcinoma. LINK TO TRANSCRIPT

  • May 31 · 8 min

    Day 3: Top Takeaways From ASCO26

    Dr. Monty Pal shares highlights from Day 3 of the 2026 ASCO Annual Meeting, including new research for the treatment of advanced CRC and mCRPC, TIL cell therapy in advanced non-uveal melanoma, and an ultra-low dose immunotherapy trial in head and neck squamous cell carcinoma. LINK TO FULL TRANSCRIPT

  • May 30 · 8 min

    Day 2: Top Takeaways From ASCO26

    Dr. Monty Pal shares highlights from Day 2 of the 2026 ASCO Annual Meeting, including a practice-changing trial in renal cell carcinoma, advances in ER-positive, HER2-negative early breast cancer, and the use of olanzapine as an effective steroid-sparing alternative for chemo-induced nausea and vomiting in pediatric cancer. LINK TO FULL TRANSCRIPT

  • May 29 · 7 min

    Day 1: Top Takeaways From ASCO26

    In the first episode of a special daily series during the 2026 ASCO Annual Meeting, Dr. Monty Pal discusses 3 abstracts, including a follow-up on the EV-302 study in urothelial carcinoma, a potential new treatment option for patients with PD-L1-positive advanced non–small cell lung cancer, and a novel psychosocial digital application that improves fatigue and distress in patients with multiple myeloma. LINK TO FULL TRANSCRIPT

  • May 14 · 27 min

    The Future of AI in Oncology: A Conversation With Google's AI Innovators

    Google DeepMind's Dr. Alan Karthikesalingam and Google research scientist Anil Palepu sit down with Dr. Monty Pal to discuss the potential of Articulate Medical Intelligence Explorer (AMIE), a large language model-based experimental medical AI system designed to augment clinical decision-making in oncology and beyond, as well as the future of AI-human collaboration and how it could reshape health care over the next decade. LINK TO FULL TRANSCRIPT

  • April 16 · 18 min

    'No Margin for Error': What to Know Before Implementing AI in Clinical Practice

    Dr. Monty Pal and Dr. Arturo Loaiza-Bonilla discuss the institutional risks in the use of artificial intelligence (AI) in clinical practice and how overreliance on AI could erode essential skills. They also highlight practical approaches, including routine "AI-off" drills, to help oncologists retain their decision-making agility. LINK TO FULL TRANSCRIPT

Showing 1–20 of 23 episodes